Is PFS Enough for Approval?, PharmaFocus: Velcade, etc.

Key Takeaways

• Personalized treatment strategies have become central to managing lung cancer brain metastases, improving patient outcomes.
• Targeted therapies and immunotherapies offer more effective, less invasive options compared to traditional methods.
• Stereotactic radiosurgery and whole-brain radiotherapy roles are evolving with novel systemic therapies.
• Multidisciplinary approaches optimize treatment plans, considering genetic mutations and patient performance status.